Literature DB >> 27623274

Initial Experience of Robotic Sleeve Resection for Lung Cancer Patients.

Xufeng Pan1, Chang Gu1, Rui Wang1, Heng Zhao1, Jianxin Shi1, Haiquan Chen2.   

Abstract

BACKGROUND: The purpose of this study was to identify the technical aspects and short-term results of robotic sleeve resection for lung cancer patients.
METHODS: Twenty-one consecutive cases of robotic sleeve resection from September 2014 to September 2015 were reviewed.
RESULTS: There were 17 single sleeve resection (bronchial) and 4 double sleeve resection (bronchial and vascular) cases. Nineteen of 21 cases (90.5%) achieved R0 resection. The mean console time was 120.4 ± 37.3 minutes. The mean operation time was 158.4 ± 42.0 minutes. There was no massive bleeding (800 mL or more) during operation. The mean intraoperative blood loss was 157.1 ± 97.8 mL. One case (4.8%) was converted to thoracotomy owing to severe calcification of lymph node. There was no intraoperative death. The overall complication rate was 19.0%. The major complications were subcutaneous emphysema (14.4%), cardiac arrhythmia (9.6%), pneumonia (9.6%), pyothorax (9.6%), bronchial anastomosis bleeding (4.8%), bronchial anastomosis leakage (4.8%), and multiple organ failure (4.8%). The 30-day mortality rate was 4.8%. The mean postoperative length of stay was 10.7 ± 7.6 days.
CONCLUSIONS: Robotic sleeve resection is technically feasible and can be carried out with acceptable short-term results.
Copyright © 2016 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2016        PMID: 27623274     DOI: 10.1016/j.athoracsur.2016.06.054

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  12 in total

1.  Robotic sleeve resections: new territory but not the final frontier.

Authors:  Byron D Patton
Journal:  J Thorac Dis       Date:  2019-04       Impact factor: 2.895

2.  Robotic lung cancer surgery: from simple to complex, from surgery to clinical study.

Authors:  Yu Han; Yajie Zhang; Chengqiang Li; Su Yang; Hecheng Li
Journal:  J Thorac Dis       Date:  2020-02       Impact factor: 2.895

3.  New era of "resection of the carina and lower trachea".

Authors:  Hideki Ujiie; Kazuhiro Yasufuku
Journal:  J Thorac Dis       Date:  2017-12       Impact factor: 2.895

4.  A systematic review and meta-analysis of thoracoscopic versus thoracotomy sleeve lobectomy.

Authors:  Yifan Zhong; Yang Wang; Xuefei Hu; Gege Wang; Yunlang She; Jiajun Deng; Lei Zhang; Qiao Peng; Yuming Zhu; Gening Jiang; Minglei Yang; Dong Xie; Chang Chen
Journal:  J Thorac Dis       Date:  2020-10       Impact factor: 2.895

5.  An antiquated contraindication for minimally invasive lung surgery: No place to staple the bronchus.

Authors:  Tuğba Coşgun; Erkan Kaba; Kemal Ayalp; Alper Toker
Journal:  Turk Gogus Kalp Damar Cerrahisi Derg       Date:  2019-10-23       Impact factor: 0.332

Review 6.  Overview of the outcomes of robotic segmentectomy and lobectomy.

Authors:  Giulia Veronesi; Pierluigi Novellis; Gianluca Perroni
Journal:  J Thorac Dis       Date:  2021-10       Impact factor: 3.005

7.  Comparison of Sleeve Lobectomy for Lung Cancer Using Mini-Thoracotomy and an Optimized Robot-Assisted Technique.

Authors:  Tao Shaolin; Feng Yonggeng; Kang Poming; Mei Longyong; Shen Cheng; Fang Chunshu; Wu Licheng; Tan Qunyou; Deng Bo
Journal:  Technol Cancer Res Treat       Date:  2021 Jan-Dec

8.  Single utility port approach in robot-assisted sleeve segmentectomy for bronchial carcinoid tumor.

Authors:  Ao Liu; Yandong Zhao; Tong Qiu; Yunpeng Xuan; Yi Qin; Xiao Sun; Rongjian Xu; Wenxing Du; Wenjie Jiao
Journal:  Thorac Cancer       Date:  2022-04-06       Impact factor: 3.223

9.  Two-port robotic sleeve lobectomy using Stratafix sutures for central lung tumors.

Authors:  Ji-Chen Qu; Wen-Tian Zhang; Lei Jiang
Journal:  Thorac Cancer       Date:  2022-04-06       Impact factor: 3.223

10.  Robotic sleeve resection for pulmonary disease.

Authors:  Chengqiang Li; Bin Zhou; Yu Han; Runsen Jin; Jie Xiang; Hecheng Li
Journal:  World J Surg Oncol       Date:  2018-04-02       Impact factor: 2.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.